Xiangda Biotechnology Covid-19 Extraction Kit Obtained EU Certification

PHASIFY ™ Viral is an effective global anti-epidemic product, with highly concentrated and purification technology, effectively improve, extract the virus content in the sample, improve the sensitivity of downstream detection, and can detect patient infection searlier, improve the sensitivity of downstream detection, enhance public confidence in the test results of the new coronavirus (COVID-19), and help control the global new crown outbreakDrJeffrey DKlausner, lead researcher at the National Institutes of Health and professor of medicine and public health at the University of California, Los Angeles, said the quality of the imported samples was a major bottleneck in the accuracy of COVID-19 testing, "and the difficulty is that because patient samples contain only a very small amount of virus RNA, As a result, most conventional fixed-phase viral RNA extraction kits experience limitations in both the sample input volume and the final elutation volume, even allowing only 1-2% of the total viral RNA in the sample to enter downstream analysisThis shows that viral RNA extraction technology plays a key role in detecting sensitivityDr Klausner said: "Compared to traditional solid-phase extraction techniques, using PHASIFY ™ viral's innovative liquid phase extraction technology can increase the number of viral RNA in standard RT-qPCR analysis by 15-30 timesImproving sample quality improves analytical sensitivity and reduces the proportion of false negative results"PHASIFY ™ viral can increase the production of SARS-CoV-2 RNAAccording to the company, its internal tests and clinical validation data show that PHASIFYTM VIRAL can reduce the Ct value of downstream detection by 3-6 cycles compared to solid phase extractionProducts have been in Wuhan City, Jinyintan Hospital for clinical research, compared to the national certification of solid gold standard extraction kit, the detection of true positive rate is higher, the effect is more idealPHASIFY ™ Viral was developed using the innovative liquid-phase sample preparation of Thesat Bio's patented Technology PHASIFY ™, which has the ability to efficiently separate and concentrate target molecules, making them easier to detectThis technology can be combined with a combination of inspection tools to improve the accuracy, convenience and reduce the cost of inspectionOther benefits of PHASIFY ™ VIRAL include the ability to increase the input of each sample taken to 600 microliters and the flexibility to adjust the final elution amount (as low as 10 microliters) to increase the concentration of viral RNA in the final sampleIt is simple and easy to operate and does not require the use of other additional equipment, such as magnetic frames and vacuum pumpsAs of today, Theonbios has developed a range of COVID-19 testing products, including antibody rapid detection kits, viral RNA extraction kits and RT-qPCR testing kits"We have been fully committed to helping to contain the spread of the new coronavirus as quickly as possible, and this CE certification from the European Union marks another step in our testing and control of the COVID-19 virus," said DrYoshihiko Ka, founder and CHIEF Executive Officer of Sundar Bio Our products have been sold in many countries and regions around the world, we are confident to enter the European market to help local health care workers and the general public, accelerate the restart of the global economy and early return to normal social life "